See other companies on Welcome to the Jungle
Wild Type
Seafood without the sea
- 101-200 employees
- B2C
- B2B
- Sustainability
- Food
- Manufacturing
- Biology
- Agriculture
- Dogpatch, San Francisco, CA
Jump to section
Company mission
To create the cleanest, most sustainable seafood on earth, starting with sushi-grade salmon.
70% employee growth in 12 months
Our take
Cellular agriculture company Wildtype creates cell-cultivated “sushi-grade” salmon, bringing the world seafood, without the sea. The company’s alternative protein offering protects wild species and the world’s oceans, all while providing consumers with real seafood equal to the most pristine wild-caught fish.
The cultivation process consists of growing the cells of a Pacific salmon in steel tanks (similar to brewery tanks), then transferring the cells into scaffolds, which guide the cells to shape each cut of fish. The company has recently partnered with Solaris Biotech, a leading innovator and manufacturer, to design next-generation bioreactor systems to help meet the growing demand for seafood.
The company’s impressive L Catterton-led funding was also backed by several high-profile investors, including Leonardo DiCaprio, Robert Downey Jr.’s FootPrint Coalition, Bezos Expeditions, and more. Though waiting for FDA approval, Wildtype already has distribution partnerships with SNOWFOX and Pokéworks, and is well set to see substantial growth.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- Mentorship, Educational Reimbursement, & Professional Growth Opportunities
- Health/Vision/Dental Coverage
- 401(k) Matching
- Stock Options
- Commuter & Culinary Benefits Packages
Company values
- Crewmates - Being crewmates means looking out for one another and creating space to bring all of who we are to work
- Transparency - Our customers demand high-quality seafood that is made with honesty, integrity, and openness
- Discovery - Bringing rigor, initiative, and perseverance to work with us every day
- Urgency - We bring urgency to our work that reflects the importance of our mission
- Accountability - Above all, we hold ourselves accountable for doing what’s right
Funding (last 2 of 4 rounds)
Nov 2022
$7.5m
LATE VC
Feb 2022
$100m
SERIES B
Total funding: $123.5m
This company has top investors
Leadership
Justin Kolbeck
(CEO & Co-Founder)Former Corporate Strategy Engagement Manager at Strategy&, Director of the Young Leadership Board at New York Needs You, and Foreign Service Officer for the U.S. Department of State.
Aryé Elfenbein
(Co-Founder)Former Cardiologist Research Fellow at Gladstone Institutes. Received their PhD in Vascular Biology and their Doctor of Medicine (MD) from Dartmouth College.